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ABSTRACT 
The biological activity and the molecular structures are the two main aspects for the QSAR study of a specific compound, which leads to 
generate a new chemical moiety. The Quantitative Structure Activity Relationship (QSAR) paradigm is based on the assumption t hat there is an 
underlying relationship between the molecular structure and biological activity. Physico-chemical properties were calculated employing the 
modeling software Win CAChe 6.1. The calculated descriptors were conformational minimum energies (CME) , HOMO energy, LUMO energy, 
heat of formation (HF), ionization potential (IP), molar refractivity(MR), Shape Index (basic kappa, order 1) (SI1), log P, electron affinity (EA), 
solvent accessible surface area (SAS). In random selection, 18 compounds were in training set and 10 in test set. Subsequently with the 
stepwise multiple linear regression analysis was carried out to achieve the best models. The equation generated was validated. The selected 
QSAR model showed correlation coefficient R2 0.7609, and cross-validated squared correlation coefficient Q2   of 0.5041 for antioxidant activity  
ANOVA of predicted value for  Variance were found as 0.063638, 201.73 and 0.112396 for group -1.51851, 86.27 and -8.151 respectively. 
Source of Variation for between and within group i.e. SS value 40522.91 df value 2, MS value 20261.45 F value 301.0527 and p-value 1.01E-17. 
The HOMO-LUMO range were 73.149 to 84.775, Molar refractivity range was observed -7.409 to -8.84, Predicted value range was -2.52559 to -
2.98191 for compound V1 to V5 and R1, R2. The result of study indicated that C5 [1-(2- hydroxyphenyl)-5-phenylpenta-2,4-dien-1-one]; is only 
inactive against Streptococcus mutans. All 3-hydroxyflavone derivatives exhibited their MIC to be in range of 250-125 µg/ml., 2,3-
dihydroflavan-3-ol derivatives exhibited their MIC to be in  range of  1000- 500 µg/ml. The chalcone derivatives exhibited their MIC to be at 
250µg/ml. 
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INTRODUCTION: 
Drug discovery is the extremely time consuming and 
expensive processes. With rapidly increasing costs, 
diminishing resources, more intense public scrutiny, greater 
government regulations, and higher expectations, this hit 
and- miss approach is not effective on economical and 
efficiency basis. The combined application of molecular 
graphics, computational pharmaceutical chemistry and 
biological data studies are comes in the field of computer 
added drug design (CADD).  These advance computer based 
techniques are helpful for the achieving to long-term goal for 
a medical analyst: the prediction of pharmacological activity 
prior to extensive chemical synthesis and biological data 
testing. 
The biological activity and the molecular structures are the 
two main aspects for the QSAR study of a specific compound, 
which leads to generate a new chemical moiety. The 
Quantitative Structure Activity Relationship (QSAR) 
paradigm is based on the assumption that there is an 
underlying relationship between the molecular structure and 
biological activity. On the basis of this assumption QSAR 
study establish a correlation between various molecular 
properties of a series of molecular compound with their well 
known biological activity. 
The antioxidant effects of flavonoids lead to many effective 
and observable pharmacological responses as cardio-
vascular, antithrombogenic, antitumor, anti-inflammatory, 
antidiarrheal, antiviral, antiplaque etc. Flavonoides are the 
well known biological response. They have the ability of 
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modification to the metabolic reaction and activity of body to 
allergic molecules, viruses and carcinogens. Thus, goal of this 
work is to syntheses flavonoids starting from commonly 
available raw materials and its evaluation for antioxidant 
and antibacterial activity. 
EXPERIMENTAL WORK: 
Selection of training and test set: 
QSAR models are used largely to screen chemical databases 
and/or virtual chemical libraries for potentially biological 
active molecules. These developments highlight the 
importance of rigorous model validation to ensure that the 
models have both the ability to explain the difference in the 
biological activity (internal validation) and the acceptable 
anticipate power e.g. external validation. For model 
validation the dataset is required to be divided into test set 
for making the QSAR model and test set for screening its  
predictive power. For any QSAR model, it is of very 
importance that the training set selected to calibrate the 
model exhibits a well-balanced distribution and contains 
representative molecules. 
Evaluation of the Model: 
The numbers of statistical methods are available for 
evaluation of the significance of the model, these methods 
are; 
1. n number of molecules ( > 20 molecules) 
2. k number of descriptors in a model (statistically n/5 
descriptors in a model) 
3. df degree of freedom (n-k-1) (higher is better) 
4. r2 coefficient of determination (> 0.7) 
5. q2 cross-validated r2 (>0.5) 
6. pred_r2 r2 for external test set (>0.5) 
7. SEE standard error of estimate (smaller is better) 
8. F-test F-test for statistical significance of the 
9. F_prob. Alpha error probability (smaller is better) 
10. Zscore Z score calculated by the randomization test 
(higher is better) 
11. best_ran_q2 highest q2 value in the randomization test 
(as low as compared to  q2) 
12. best_ran_r2 highest r2 value in the randomization test 
(as low as compared to r2) alpha test (<0.01)statistical 
significance parameter by randomization 
Interpretation of Model: 
Multiple regressions are largely used method for 
construction of QSAR model. It is very easy to interpret a 
regression procedure modal, which contribution of each 
descriptor could be seen by the magnitude and sign of its 
regression coefficient. A descriptor coefficient magnitude 
shows its relative contribution w.r.t other descriptors and 
sign indicates whether it is directly (positive) or inversely 
(negative) proportional to the activity. 
 
 
Procedure:  
2.5 mmol of the benzaldehyde derivative and 2.5 mmol of the 
acetophenone derivative were measured accurately and 
placed in a mortar. To this added 3 pellets of NaOH (7.5 
mmole). Mixture was ground for about 5–10 min. The 
mixture was turned yellow and pasty after a few times of 
grinding. Grinding was continued until the mixture turn into 
a solid mass and the solid became powdery. 10 mL of water 
added to the mortar at the last minute of the  grinding 
period. Product was mixed properly with the water,  using 
the spatula solid product was dislodged from the mortar’s 
wall and filtered. 
 
 
Procedure:  
To a mixture of chalcone [0.01mole] in ethyl alcohol [85ml] 
was added 20 present aqueous sodium hydroxide [10ml] 
with continues mixing, thereafter by careful addition of 
hydrogen peroxide [18ml] 20% solution over a period of 
0.5hr.The reaction mixture was mixing by continues stir for 
3 hrs. at 300c temperature and then put it onto crushed ice 
containing 5M Hydrochloric acid. The precipitate then 
filtered.  It washed with water and then dried in hot oven. 
The dried powder was crystallized from chloroform: methyl 
alcohol [9:1]. 
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Procedure:  
A mixture of powdered 2-hydroxychalcone (0.45 mmol) and 
aq. Sodium hydroxide solution (8 N, 1.0 ml) and a 30% H2O2 
solution (0.25 g) was mixed with continues stirring at room 
temperature for 2 hours. The raw product was filtered off. It 
was washed with water. The product was dried in a 
desiccator to give flavanol and recrystallization of the crude 
product from methyl alcohol. 
Characterization of Final Compounds: 
The identification & characterization of the prepared 
compounds were performed on the basis of their 
physiochemical and spectral data. Such as thin layer 
chromatography (TLC), melting point (MP), UV-visible 
analysis(UV), infrared spectroscopy (IR) and Nuclear 
Magnetic resonance method (1H NMR). 
RESULT AND DISCUSSION: 
Physico-chemical properties were calculated employing the 
modeling software Win CAChe 6.1. The calculated 
descriptors were conformational minimum energies(CME) , 
HOMO energy, LUMO energy, heat of formation (HF), 
ionization potential (IP), molar refractivity(MR), Shape 
Index (basic kappa, order 1) (SI1), log P, electron affinity 
(EA), solvent accessible surface area (SAS). The above 
properties served as source data for the statistical software 
and a correlation matrix was prepared to select the 
parameters with a very low inter-correlation and maximum 
correlation with the studied compounds anti- oxidant 
activity. In random selection, 18 compounds were in training 
set and 10 in test set. Subsequently with the stepwise 
multiple linear regression analysis was carried out to 
achieve the best models. 
 
Table 1: Substitution pattern of the series of flavonoids ex amined for their antiradical activity  
Compound RSAexp. /% R3 R5 R7 R8 R2' R3' R4' R'5 C2=C3 
Morin 96.5 OH OH OH H OH H OH H + 
Taxifolin 94.8 OH OH OH H H OH OH H - 
Kaempferol 93.5 OH OH OH H H H OH H + 
Fustin 91.9 OH H OH H H OH OH H - 
Galangin 91.8 OH OH OH H H H H H + 
Rutin 90.9 Ogl OH OH H H OH OH H + 
Quercetin 89.8 OH OH OH H H OH OH H + 
luteolin 7-gl 87.6 H OH Ogl H H OH OH H + 
quercetin 3,7,-digl 86.8 Ogl OH Ogl H H OH OH H + 
laricytrin 84.6 OH OH OH H H OH OH OMe + 
laricetrin-3'-gl 83.8 OH OH OH H H Ogl OH OMe + 
robinetin 82.3 OH H OH H H OH OH OH + 
fisetin 79 OH H OH H H OH OH H + 
myricetin 72.8 OH OH OH H H OH OH OH + 
kaempferol 70.6 Ogl OH Ogl H H H OH H + 
Apigenin-7-gl 34.8 H OH Ogl H H H OH H + 
hesperetin 30 H OH OH H H OH OMe H - 
vitexin 21 H OH OH Ogl H H OH H + 
3,5,7,3',4',5'-hexamethoxyflavone 12.6 OMe OMe OMe H H OMe OMe OMe + 
naringenin 6.3 H OH OH H H H OH H - 
Naringin 4.7 H OH Ogl H H H OH H - 
7-hydroxyflavone 2.8 H H OH H H H H H + 
Flavanone 2.6 H H H H H H H H - 
Flavones 1.5 H H H H H H H H + 
Chrysin 1.1 H OH OH H H H H H + 
Apigenin 0.7 H OH OH H H H OH H + 
8-methoxyflavone 0.7 H H H OMe H H H H + 
5-hydroxyflavone 0.6 H OH H H H H H H + 
Experimental values as RSA, radical scavenging activity (percents) were taken from ref. 26, gl: glycosyl 
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Table 2: physic-chemical parameters of flavonoids 
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8.82 
 
0.19 
 
-0.76 
 
105.74 
 
23.66 
 
-206.16 
 
398.7 
5-hydroxyflavone 0.22 0.75 -33.54 -9.13 9.13 2.03 -0.75 68.67 13.01 -33.54 252.7 
7-hydroxyflavone -0.44 0.87 -37.80 -9.34 9.34 2.03 -0.87 68.67 13.01 -37.80 255.0 
8-methoxyflavone 0.15 0.78 -27.74 -8.98 8.98 2.07 -0.78 73.43 13.96 -27.74 272.5 
Naringin -0.67 0.29 - 567.09 -9.12 9.12 0.09 -0.29 133.73 32.40 -567.09 520.9 
Apigenin Glucoside -1.54 0.89 -360.20 -9.08 9.08 0.00 -0.89 104.49 24.14 -360.20 406.7 
Apigenin 0.15 0.78 -123.03 -9.05 9.05 1.47 -0.78 72.05 14.92 -123.03 273.1 
Chrysin -0.04 0.78 -78.45 -9.23 9.23 1.75 -0.78 70.36 13.96 -78.45 262.7 
Fisetin -1.89 0.98 -154.49 -8.74 8.74 0.56 -0.98 73.73 15.88 -154.49 280.7 
Flavanone -0.41 0.41 -16.59 -9.30 9.30 2.84 -0.41 65.35 12.06 -16.59 243.4 
Flavones -0.17 0.85 6.90 -9.27 9.27 2.32 -0.85 66.97 12.06 6.90 244.7 
Fustin -1.96 0.51 -184.42 -9.09 9.09 1.56 -0.51 71.77 15.88 -184.42 281.8 
Galangin -1.96 0.79 -111.31 -8.85 8.85 0.85 -0.79 72.04 14.92 -111.31 268.7 
Hesperitin -1.47 0.36 -181.60 -8.84 8.84 1.74 -0.36 76.89 16.84 -181.60 298.5 
Kaempferol dirhamnose -1.84 0.82 -532.89 -8.94 8.94 -2.96 -0.82 134.13 32.40 -532.89 517.8 
kaempferol -1.97 0.79 -155.60 -8.71 8.71 0.56 -0.79 73.73 15.88 -155.60 278.8 
laricetrin 3-O-glucoside -1.92 1.01 -497.00 -8.75 8.75 -1.72 -1.01 114.68 28.02 -497.00 443.2 
Laricytrin -1.93 0.86 -225.57 -8.69 8.69 0.03 -0.86 81.89 18.78 -225.57 314.6 
luteoline glucoside -1.94 0.87 -395.90 -8.91 8.91 -0.28 -0.87 106.18 25.10 -395.90 413.1 
Morin -1.98 0.68 -195.33 -8.53 8.53 0.28 -0.68 75.43 16.84 -195.33 285.8 
Myricetin -1.86 0.95 -235.10 -8.79 8.79 -0.01 -0.95 77.12 17.81 -235.10 296.7 
Naringenin -0.80 0.35 -147.57 -9.24 9.24 1.99 -0.35 70.43 14.92 -147.57 270.8 
Quercetin Diglucoside -1.94 1.74 -559.06 -7.84 7.84 -4.41 -1.74 130.08 34.34 -559.06 517.5 
Quercetin -1.95 0.88 -195.45 -8.68 8.68 0.28 -0.88 75.43 16.84 -195.45 288.5 
Robenitin -1.92 1.04 -194.10 -8.85 8.85 0.28 -1.04 75.43 16.84 -194.10 289.1 
Rutin -1.96 0.48 -617.39 -9.00 9.00 -4.53 -0.48 137.27 34.34 -617.39 513.6 
Taxifolin -1.98 0.43 -225.85 -9.05 9.05 1.27 -0.43 73.46 16.84 -225.85 290.2 
Vitaexine -1.32 0.92 -399.67 -9.01 9.01 -0.28 -0.92 106.18 25.10 -399.67 398.6 
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Figure 1: Experimental  vs predicted 
Table 3: ANOVA of predicted value  
Groups Count Sum Average Variance 
-1.51851 9 -14.6228 -1.62475 0.063638 
86.27 9 694.379 77.15322 201.73 
-8.151 9 -72.489 -8.05433 0.112396 
 
Source of Variation SS df MS F p-value F-crit 
Between Groups 40522.91 2 20261.45 301.0527 1.01E-17 3.402826 
Within Groups 1615.248 24 67.30202    
Total 42138.16 26     
 
Table 4: predicted activity of synthesized compounds  
Comp. code HOMO-LUMO Molar refractivity Prediction 
V1 68.652 -7.927 -2.79822 
V2 75.115 -7.769 -2.76108 
V3 83.08 -7.43 -2.52559 
V4 84.775 -7.409 -2.62972 
V5 78.97 -7.595 -2.67344 
R1 66.685 -8.841 -2.98191 
R2 73.149 -8.778 -2.87362 
 
 
Figure 2: General structure of 3-hydroxy flavonoid derivatives 
Table 5:  Different substitution of synthesized compounds  
C
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COMPOUND NAME 
SU BSTITUENTS 
X R 5 R 6 R 7 R 8 
V 1 3-hydroxy-2-phenyl-4H-chromen-4- one 2 - Hydroxyphenyl H H H H 
V 2 3-hydroxy-2-(4-methoxyphenyl)- 4H-chromen-4-one 4 - Isopropylphenyl H H H H 
V 3 3-hydroxy-2-p-tolyl-4H-chromen-4- one 4 - Methylphenyl H H H H 
V 4 3,7-dihydroxy-2-(2-hydroxyphenyl)- 4H-chromen-4-one 2 - Hydroxyphenyl H H OH H 
V 5 3,7-dihydroxy-2-(4-isopropylphenyl)- 4H-chromen-4-one 4 - Isopropylphenyl H H OH H 
V 6 3,7-dihydroxy-2-p-tolyl-4H-chromen- 4-one 4 - Methylphenyl H H OH H 
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Figure 3: General structure of 2, 3-dihydroxy flavan-3-ol derivatives 
Table 5:  Different substitution of 2, 3 -dihydroxy flavan-3-ol derivatives 
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Compound Name 
Substituents 
X R 5 R 6 R 7 R 8 
R1 3-hydroxy-2-phenyl-2,3-dihydro- 4H-chromen-4-one 2 - Hydroxyphenyl H H H H 
R2 2,3 -dihydro-3-hydroxy-2-(4- 
isopropylphenyl)chromen-4-one 
4 - Isopropylphenyl H H H H 
R3 2,3-dihydro-3-hydroxy-2-p- tolylchromen-4-one 4 - Methylphenyl H H H H 
R4 2,3-dihydro-3,7-dihydroxy-2-(2- 
hydroxyphenyl)chromen-4-one 
2 - Hydroxyphenyl H H OH H 
R5 2,3-dihydro-3,7-dihydroxy-2-(4- 
isopropylphenyl)chromen-4-one 
4 - Isopropylphenyl H H OH H 
R6 3, 7-dihydroxy-p-tolylchromen-4- one 4 - Methylphenyl H H OH H 
 
Minimum inhibitory concentration: 
On observation of positive results of antimicrobial activity, 
the MICs of synthesized compounds were determined by 
tube dilution method. Studies indicated the requirement of 
inhibitory concentration in order “chalcone derivatives > 2,3-
dihydroflavan-3-ol derivatives > 3-hydroxyflavone 
derivatives. The result of study indicated that C5 [1-(2- 
hydroxyphenyl)-5-phenylpenta-2,4-dien-1-one]; is only 
inactive against Streptococcus mutans. All 3-hydroxyflavone 
derivatives exhibited their MIC to be in range of 250-125 
µg/ml., 2,3-dihydroflavan-3-ol derivatives exhibited their 
MIC to be in  range of  1000- 500 µg/ml. The chalcone 
derivatives exhibited their MIC to be at 250 µg/ml.
 
Table 6:  MIC of flavonoid derivatives with Streptococcus mutans 
Compound 
code 
% Transmittance 
1000 µg/ml 500 µg/ml 250 µg/ml 125 µg/ml 
J1 37 34 30 17 
J2 24 26 29 16 
J3 18 27 17 19 
J4 33 35 28 19 
J5 30 31 29 26 
J6 31 39 34 27 
V1 30 37 41 25 
V2 27 33 30 27 
V3 32 34 36 12 
V4 33 36 25 15 
V5 33 35 28 19 
V6 32 33 30 28 
R1 30 39 35 27 
R2 47 24 21 25 
R3 34 15 18 15 
R4 58 43 23 27 
R5 44 48 32 30 
R6 53 16 13 18 
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Figure 4: MIC of 2-hydroxy Chalcone derivatives 
 
Figure 5: MIC of 3-hydroxy flavone derivatives 
 
Figure 6: MIC of 2, 3-dihydroxy flavan-3-ol derivatives 
 
CONCLUSION: 
A QSAR study was performed on a series of flavonoids using 
WIN CAChe 6.1 and Vlife MDS 3.5 to explore the physico-
chemical parameters responsible for their antioxidant 
activity. The equation generated was validated. The selected 
QSAR model showed correlation coefficient R2 0.7609, and 
cross-validated squared correlation coefficient Q2   of 0.5041 
for antioxidant activity. The developed model indicated that 
positive dependence of molar refractivity & HOMO-LUMO 
gap on the antioxidant activity of flavonoids. The newly 
synthesized flavonoid derivatives were screened for 
antioxidant, antimicrobial activity. The results of 
pharmacological screenings are satisfactory. Most of the 
derivatives have shown comparable antioxidant activity in 
relation to standard Ascorbic acid. These derivatives were 
found to have inhibitory effect against Streptococcus mutans. 
The result of antimicrobial study against microorganism 
Streptococcus mutans shows flavonoid derivatives possess 
antibacterial activity. 
REFERENCES: 
1. Bilkis jahan Lumbiny1 , Zhang hui, Antiaging, Antioxidant 
Flavonoids; Synthesis, Antimicrobial Screening as well as 3d 
qsar COMFA Models for the Prediction of Biological Activity, j. 
asiat. soc. bangladesh, sci. 2013; 39(2):191-199. 
2. Mostahar, S., P. Khatun and M. A. Islam. Synthesis of two vanillin 
ring containing flavones by different methods and studies of 
their antibacterial and antifungal activities. Journal of Biological 
Science. 2007; 7(3):514-519. 
3. Patrick, G. L. 2001. An Introduction to Medicinal Chemistry. 
Oxford University Press. U. K. 450- 465.  
4. Putambaker, D. S., R. Giridhar and M. 3D-QSAR CoMFA/CoMSIA 
studies on 5- aryl-2, 2-dialkyl-4-phenyl-3 (2H)-furanone 
derivatives as selective COX-2 Inhibitors. Acta Pharm. 2006; 
56:157-174. 
5. Samee, W., J. Ungwitayatorn and J. Pimthon. 3D-QSAR Studies on 
Phthalimide Derivatives as HIV-1Reverse Transcriptase 
Inhibitors. Science Asia. 2004; 30:81- 88. 
6. Shirley, B.W. Flavonoid Biosynthesis. A colorful Model for 
Genetics, Biochemistry, Cell Biology, Biotechnology. Plant 
Physiology. 2001; 126:485-493.  
Sharma et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2019; 9(4):765-773 
ISSN: 2250-1177                                                                                  [772]                                                                                 CODEN (USA): JDDTAO 
7. Tapas, A. R., D. M. Sharker and R.B. Kakde. Flavonoids as 
Neutraceuticals: A Review. Tropical Journal of Pharmaceutical 
Research. 2008; 7(3):1089-1099. 
8. Young, D. C. Computational Chemistry; A Practical Guide for 
Applying Techniques to Real World Problems; John Willy and 
Sons. 2001; 243-249. 
9. Chandra, P. Yadav, A.  Patni, B.; Mishra, A.P.; Nautiyal, A.R. 
Antimicrobial resistance and the alternative resources with 
special emphasis on plant-based antimicrobials–A review. 
Plants 2017; 6:16.   
10. Gupta, P.D.; Birdi, T.J. Development of botanicals to combat 
antibiotic resistance. J. Ayur. Integr. Med. 2017; 8:266–275.  
11. Zheng, J.; Huang, C.; Yang, B.; Kallio, H. Regulation of 
phytochemicals in fruits and berries by environmental 
variation—Sugars and organic acids. J. Food Biochem. 2019, 43, 
e12642. J. Clin. Med. 2020, 9; 109:13 of 17 
12. Özçelik, B. Kartal, M. Orhan, I. Cytotoxicity, antiviral and 
antimicrobial activities of alkaloids, flavonoids, and phenolic 
acids. Pharm. Biol. 2011; 49:396–402.  
13. Barbieri, R. Coppo, E.; Marchese, A. Daglia, M. Sobarzo-Sánchez, 
Nabavi, S.M. Phytochemicals for human disease: An update on 
plant-derived compounds antibacterial activity. Microbiol. Res. 
2017; 196:44–68.  
14. Fialova, S. Rendekova, K. Mucaji, P. Slobodnikova, L. Plant 
natural agents: Polyphenols, alkaloids and essential oils as 
perspective solution of microbial resistance. Curr. Org. Chem. 
2017; 21:1875–1884.  
15. Khameneh, B. Iranshahy, M.; Soheili, B.S.F. Review on plant 
antimicrobials: A mechanistic viewpoint. Antimicrob. Resist. 
Infect. Control 2019; 8:118.  
16. Gutiérrez-Grijalva, E.P. Picos-Salas, M.A. Leyva-López, N. Criollo-
Mendoza. Flavonoids and phenolic acids from oregano: 
Occurrence, biological activity and health benefits. Plants 2018, 
7, 2.   
17. Jungbauer, A. Medjakovic, S. Anti-inflammatory properties of 
culinary herbs and spices that ameliorate the effects of 
metabolic syndrome. Maturitas 2012, 71, 227–239.   
18. Goncalves, S. Moreira, E. Grosso, C. Andrade,  Phenolic profile, 
antioxidant activity and enzyme inhibitory activities of extracts 
from aromatic plants used in mediterranean diet. J. Food Sci. 
Technol. 2017, 54, 219–227.  
19. Mileo, A.M. Nisticò, P. Miccadei, S. Polyphenols: 
Immunomodulatory and therapeutic implication in colorectal 
cancer. Front. Immunol. 2019, 10, 729. [CrossRef] [PubMed]  
20. Singh, A.K. Cabral, C. Kumar, R. Ganguly, R. Rana, H.K. Gupta, A. 
Lauro, M.R. Carbone, C. Reis, F. Pandey, A.K. Beneficial effects of 
dietary polyphenols on gut microbiota and strategies to 
improve delivery efficiency. Nutrients 2019, 11, 2216.  
21. Firrman, J. Liu, L.S. Yam, K. A review on flavonoid apigenin: 
Dietary intake, ADME, antimicrobial effects, and interactions 
with human gut microbiota. BioMed Res. Int. 2019, 2019, 
7010467.  
22. Chua, L.S. A review on plant-based rutin extraction methods and 
its pharmacological activities. J. Ethnopharmacol. 2013, 150, 
805–817.   
23. Enogieru, A.B. Haylett, W. Hiss, D.C. Bardien, S. Ekpo, O.E. Rutin 
as a potent antioxidant: Implications for neurodegenerative 
disorders. Oxid. Med. Cell Longev. 2018, 2018, 6241017.  
24. Edwards, P.N. Talent, N. Dickinson, T.A. Shipley, P.R. A review of 
the chemistry of the genus Crataegus. Phytochemistry 2012, 79, 
5–26. 
25. Yamaguchi, K.K.L. Pereira, L.F.R. Lamarão, C.V. Lima, E.S. da 
Veiga-Junior, V.F. Amazon acai: Chemistry and biological 
activities: A review. Food Chem. 2015, 179, 137–151.  
26. Yuan, L. Wang, J. Wu, W. Liu, Q. Liu, X. Effect of isoorientin on 
intracellular antioxidant defence mechanisms in hepatoma and 
liver cell lines. Biomed. Pharmacother. 2016, 81, 356–362.  
27. Mani, R. Natesan, V. Chrysin: Sources, beneficial 
pharmacological activities, and molecular mechanism of action. 
Phytochemistry 2018, 145, 187–196.  
28. Knekt P, Jarvinen R, Seppanen R., Dietary flavonoids and the risk 
of lung cancer and other malignant neoplasms. Am J Epidemiol, 
(1997), 146:223–30 
29. Robak J, Gryglewski RJ., Pol J Pharmacol , (1996), 48:555–64. 
30. Gurdeep Chatwal, Organic Chemistry Of Natural Products, Vol.II, 
(2002), Himalaya Publishing House, 225-245 
31.  O.P.Agrawal, Chemistry of Organic Natural Products, Vol.II, 
(2001),Goel Publishing House, Meerut, 234-257. 
32. O˙zarowski, M. Piasecka, A. Paszel-Jaworska, A. Chaves, D.S. 
Romaniuk, A. Rybczy ´nska, M. Gryszczynska, A. Sawikowska, A. 
Kachlicki, P. Mikolajczak, P.L. et al. Comparison of bioactive 
compounds content in leaf extracts of Passiflora incarnata, P. 
caerulea and P. alata and in vitro cytotoxic potential on 
leukemia cell lines. Rev. Bras. Farmacogn. 2018, 28, 79–191.  
33. Naz, S. Imran, M. Rauf, A. Orhan, I.E. Shariati, M.A. Haq, I.U. 
Yasmin, I. Shahbaz, M. Qaisrani, T.B. Shah, Z.A. et al. Chrysin: 
Pharmacological and therapeutic properties. Life Sci. 2019, 235, 
116797.  
34. Przybyłek, I. Karpi nski, T.M. Antibacterial properties of 
propolis. Molecules 2019, 24, 2047.  
35. Alam, M.A. Subhan, N. Rahman, M.M. Uddin, S.J. Reza, H.M.  
Sarker, S.D. Effect of Citrus flavonoids, naringin and naringenin, 
on metabolic syndrome and their mechanisms of action. Adv. 
Nutr. 2014, 5, 404–417.  
36. Viljakainen, S. Visti, A. Laakso, S. Concentrations of organic acids 
and soluble sugars in juices from Nordic berries. Acta Agric. 
Scand. Sect. B Soil Plant Sci. 2002, 52, 101–109.  
37. Pande, G. Akoh, C.C. Organic acids, antioxidant capacity, phenolic 
content and lipid characterisation of Georgia-grown 
underutilized fruit crops. Food Chem. 2010, 120, 1067–1075.  
38. Nour, V. Trandafir, I. Ionica, M.E. Ascorbic acid, anthocyanins, 
organic acids and mineral content of some black and red currant 
cultivars. Fruits 2011, 66, 353–362. J. Clin. Med. 2020, 9, 109 14 
of 17  
39. Kaume, L. Howard, L.R. Devareddy, L. The blackberry fruit: A 
review on its composition and chemistry, metabolism and 
bioavailability, and health benefits. J. Agric. Food Chem. 2012, 
60, 5716–5727. 
40.  Wang, Y. Johnson-Cicalese, J. Singh, A.P. Vorsa, N. 
Characterization and quantification of flavonoids and organic 
acids over fruit development in American cranberry (Vaccinium 
macrocarpon) cultivars using HPLC and APCI-MS/MS. Plant Sci. 
2017, 262, 91–102.  
41. Denev, P. Kratchanova, M. Petrova, I. Klisurova, D. Georgiev, Y. 
Ognyanov, M. Yanakieva, I. Black chokeberry (Aronia 
melanocarpa (Michx.) Elliot) fruits and functional drinks differ 
significantly in their chemical composition and antioxidant 
activity. J. Chem. 2018, 2018, 9574587.  
42. Adamczak, A. Buchwald, W. Kozłowski, J. Variation in the 
content of flavonols and main organic acids in the fruit of 
European cranberry (Oxycoccus palustris Pers.) growing in 
peatlands of North-Western Poland. Herba Pol. 2011, 57, 5–15.  
43. Jurikova, T. Mlcek, J. Skrovankova, S. Sumczynski, D. Sochor, J. 
Hlavacova, I. Snopek, L. Orsavova, J. Fruits of black chokeberry 
Aronia melanocarpa in the prevention of chronic diseases. 
Molecules 2017, 22, 944.]  
44. Santana-Gálvez, J. Cisneros-Zevallos, L. Jacobo-Velázquez, D.A. 
Chlorogenic Acid: Recent advances on its dual role as a food 
additive and a nutraceutical against metabolic syndrome. 
Molecules 2017, 22, 358.  
45. Meinhart, A.D. Damin, F.M. Caldeirao, L. Silveira, T.F.F. Filho, J.T. 
Godoy, H.T. Chlorogenic acid isomer contents in 100 plants 
commercialized in Brazil. Food Res. Int. 2017, 99, 522–530.  
46. Shekarchi, M. Hajimehdipoor, H. Saeidnia, S. Gohari, A.R. 
Hamedani, M.P. Comparative study of rosmarinic acid content in 
some plants of Labiatae family. Pharmacogn. Mag. 2012, 8, 37–
41.  
47. O zarowski, M. Mikołajczak, P. Bogacz, A. Gryszczy nska, A. 
Kujawska, M. Jodynis-Libert, J. Piasecka, A. Napieczynska, H. 
Szulc, M. Kujawski, R. et al. Rosmarinus officinalis L. leaf extract 
improves memory impairment and affects acetylcholinesterase 
and butyrylcholinesterase activities in rat brain. Fitoterapia 
2013, 91, 261–271.  
48. Ozarowski, M. Mikolajczak, P.L Piasecka, A. Kachlicki, P. 
Kujawski, R. Bogacz, A. BartkowiakWieczorek, J. Szulc, M. 
Kaminska, E. Kujawska, M. et al. Influence of the Melissa 
officinalis leaf extract on long-term memory in scopolamine 
animal model with assessment of mechanism of action. Evid. 
Based Complem. Alternat. Med. 2016, 2016. 
49. Balcke, G.U. Handrick, V. Bergau, N. Fichtner, M. Henning, A. 
Stellmach, H. Tissier, A. Hause, B. Frolov, A. An UPLC-MS/MS 
method for highly sensitive high-throughput analysis of 
phytohormones in plant tissues. Plant Methods 2012, 8,  
Sharma et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2019; 9(4):765-773 
ISSN: 2250-1177                                                                                  [773]                                                                                 CODEN (USA): JDDTAO 
50.  Toiu, A. Vlase, L. Oniga, I. Benedec, D. Tăma¸s, M. HPLC analysis 
of salicylic derivatives from natural products. Farmacia 2011, 
59, 106–112.  
51. Bijttebier, S. van der Auwera, A. Voorspoels, S. Noten, B. 
Hermans, N. Pieters, L. Apers, S. A first step in the quest for the 
active constituents in Filipendula ulmaria (meadowsweet): 
Comprehensive phytochemical identification by liquid 
chromatography coupled to quadrupole-orbitrap mass 
spectrometry. Planta Med. 2016, 82, 559–572.  
52. Nabavi, S.F. Habtemariam, S. Ahmed, T. Sureda, A. Daglia, M. 
Sobarzo-Sánchez, E. Nabavi, S.M. Polyphenolic composition of 
Crataegus monogyna Jacq.: From chemistry to medical 
applications. Nutrients 2015, 7, 7708–7728.  
53. Kerasioti, E. Apostolou, A. Kafantaris, I. Chronis, K. Kokka, E. 
Dimitriadou, C. Tzanetou, E.N. Priftis, A. Koulocheri, S.D. 
Haroutounian, S. et al. Polyphenolic composition of Rosa canina, 
Rosa sempervivens and Pyrocantha coccinea extracts and 
assessment of their antioxidant activity in human endothelial 
cells. Antioxidants 2019, 8, 92  
54. Siriwong, S. Thumanu, K. Hengpratom, T. Eumkeb, G. Synergy 
and mode ofaction of ceftazidime plus quercetin or luteolin on 
Streptococcus pyogenes. Evid. Based Complem. Altern. Med.  
2015.  
55. Betts, J.W. Sharili, A.S. Phee, L.M. Wareham, D.W. In vitro activity 
of epigallocatechin gallate and quercetin alone and in 
combination versus clinical isolates of methicillin-resistant 
Staphylococcus aureus. J. Nat. Prod. 2015, 78, 2145–2148.  
56. Hossion, A.M. Zamami, Y. Kandahary, R.K. Tsuchiya, T. Ogawa, 
W. Iwado, A. Quercetin diacylglycoside analogues showing dual 
inhibition of DNA gyrase and topoisomerase IV as novel 
antibacterial agents. J. Med. Chem. 2011, 54, 3686–3703.  
57. Chen, C.C. Huang, C.Y. Inhibition of Klebsiella pneumoniae DnaB 
helicase by the flavonol galangin. Protein J. 2011, 30, 59–65.  
58. Lin, H.H. Huang, C.Y. Characterization of flavonol inhibition of 
DnaB helicase: Real-time monitoring, structural modeling, and 
proposed mechanism. J. Biomed. Biotechnol. 2012, 2012, 
735368.   
59. Huang, Y.H. Huang, C.C. Chen, C.C. Yang, K.; Huang, C.Y. Inhibition 
of Staphylococcus aureus PriA helicase by flavonol kaempferol. 
Protein J. 2015, 34, 169–172.  
60. Farhadi, F. Khameneh, B. Iranshahi, M. Iranshahy, M. 
Antibacterial activity of flavonoids and their structure-activity 
relationship: An update review. Phytother. Res. 2019, 33, 13–40.  
61. Echeverría, J. Opazo, J. Mendoza, L. Urzúa, A. Wilkens, M. 
Structure-activity and lipophilicity relationships of selected 
antibacterial natural flavones and flavanones of chilean flora. 
Molecules 2017, 22, 608.  
62. Xie, Y. Chen, J. Xiao, A. Liu, L. Antibacterial activity of 
polyphenols: Structure-activity relationship and influence of 
hyperglycemic condition. Molecules 2017, 22, 1913.  
63. Bouarab-Chibane, L. Forquet, V. Lantéri, P. Clément. 
Antibacterial properties of polyphenols: Characterization and 
QSAR (Quantitative Structure–Activity Relationship) models. 
Front. Microbiol. 2019, 10, 829.  
64. Morimoto, Y. Baba, T. Sasaki, T. Hiramatsu, K. Apigenin as an 
anti-quinolone-resistance antibiotic. Int. J. Antimicrob. Agents. 
2015, 46, 666–673.  
65. Amin, A. Vincent, R. Séverine, M. Rosmarinic acid and its methyl 
ester as antimicrobial components of the hydromethanolic 
extract of Hyptis atrorubens Poit. (Lamiaceae). Evid. Based 
Complem. Alternat. Med. 2013, 2013, 604536.  
66. Ronald L Prior, Fruits and vegetables in the prevention of 
cellular oxidative damage, American Journal of Clinical Nutrition, 
(2003), 78(3): 570S-578S. 
67. Finar, Stereochemistry of Natural products, 5th edition, Vol 
II,ELBS longman publication, 785. 
68. Gary R. Beecher, Overview of Dietary Flavonoids: Nomenclature, 
Occurrence and Intake, The American Society for Nutritional 
Sciences J. Nutr., (2003), 133:3248S-3254S.  
69. Oyvind M. Andersen, Kenneth R. Markham, Flavonoids: 
Chemistry, Biochemistry, and Applications, (2006), CRC Press.  
70. Lichard A. Larson, Naturally Occuring Antioxidants 
71. De Groot H. Reactive oxygen species in tissue injury., 
Hepatogastroenterology (1994),41:328–32. 
72. Robak J, Gryglewski RJ., Pol J Pharmacol , (1996), 48:555–64. 
73. Hollman PC, Katan MB. Dietary flavonoids: intake, health effects 
and bioavailability,  Food Chem Toxicol , (1999), 37:937–42 
74. Okushio K, Matsumoto N, Kohri T, Suzuki M, Nanjo F, Hara Y., 
Absorption of tea catechins into rat portal vein.,  Biol Pharm 
Bull, (1996), 19:326–9 
75. Piskula MK, Terao J., Accumulation of (-)-epicatechin 
metabolites in rat plasma after oral administration and 
distribution of conjugation enzymes in rat tissues. J Nutr, 
(1998), 128:1172–8. 
 
 
 
